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ABSTRACT: Polymersomes are attractive nanocarriers for hydrophilic and lipophilic drugs; they are more stable than
liposomes, tunable, and relatively easy to prepare. The copolymer composition and molar mass are critical features that
determine the physicochemical properties of the polymersomes including the rate of drug release. We used the triblock-
copolymer, poly(2-methyl-2-oxazoline)-block-poly-(dimethysiloxane)-block-poly(2-methyl-2-oxazoline) (PMOXA−PDMS−
PMOXA), to form amphipathic polymersomes capable of loading proteins and small hydrophobic agents. The selected
agents were unstable neurotrophins (nerve growth factor and brain-derived neurotrophic factor), a large protein CD109, and
the fluorescent drug curcumin. We prepared, characterized, and tested polymersomes loaded with selected agents in 2D and 3D
biological models. Curcumin-loaded and rhodamine-bound PMOXA−PDMS−PMOXA polymersomes were used to visualize
them inside cells. N-Methyl-D-aspartate receptor (NMDAR) agonists and antagonists were also covalently attached to the
surface of polymersomes for targeting neurons. Labeled and unlabeled polymersomes with or without loaded agents were
characterized using dynamic light scattering (DLS), UV−vis fluorescence spectroscopy, and asymmetrical flow field-flow
fractionation (AF4). Polymersomes were imaged and tested for biological activity in human and murine fibroblasts, murine
macrophages, primary murine dorsal root ganglia, and murine hippocampal cultures. Polymersomes were rapidly internalized
and there was a clear intracellular co-localization of the fluorescent drug (curcumin) with the fluorescent rhodamine-labeled
polymersomes. Polymersomes containing CD109, a glycosylphosphatidylinositol-anchored protein, promoted cell migration in
the model of wound healing. Nerve growth factor-loaded polymersomes effectively enhanced neurite outgrowth in dissociated
and explanted dorsal root ganglia. Brain-derived neurotrophic factor increased dendritic spine density in serum-deprived
hippocampal slice cultures. NMDAR agonist- and antagonist-functionalized polymersomes targeted selectively neurons over
glial cells in mixed cultures. Collectively, the study reveals the successful incorporation into polymersomes of biologically active
trophic factors and small hydrophilic agents that retain their biological activity in vitro, as demonstrated in selected central and
peripheral tissue models.
■ INTRODUCTION
In living cells, many cellular functions are performed by
nanometer-scale vesicles.1,2 Biological vesicles store substances,
such as neurotransmitters, and control the extent of their
release.3−5 There is a current interest to use cellular vesicles,
most notably exosomes,6−8 as carriers to deliver drugs, in view
of their compatibility with cells and organs. Still, in the context
of therapeutic carriers, biological vesicles have few limitations
such as complex composition, limited stability, and modest
loading of either lipophilic drugs or proteins.9 Synthetic
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vesicles constructed with amphiphilic block copolymers, or
polymersomes, are designed to overcome these limitations.10,11
They accommodate lipophilic compounds in their membrane
and hydrophilic agents in their aqueous core.11−15 Like most
nanocarriers, polymersomes, were primarily developed as
carriers for anticancer agents.16−20 Stimulus-controlled drug
delivery from polymersomes has been demonstrated as well,
using triggers such as changes in pH or in temperature.10,20−24
There is such a diversity in polymer composition, structure,
and functionality, that it is possible to design polymersomes
adjusted to complement the properties of their cargo, from
small synthetic molecules and peptides to large biological
compounds such as proteins.25 We opted for self-assembling
polymersomes made of the triblock copolymer, poly(2-methyl-
2-oxazoline)-block-poly-(dimethysiloxane)-block-poly(2-meth-
yl-2-oxazoline) (PMOXA−PDMS−PMOXA), as their suit-
ability for protein protection and transport was reported
earlier.26 Moreover, PMOXA, which is known for its
nonfouling properties, provides stealth properties to the
polymersomes.27−29
We assessed polymersomes in biological models in 2D
(“wound in the dish”) and 3D explanted ganglia30 with more
complex structures consisting of different cell populations.
Under normal conditions, wound healing occurs through a
multistage pathway that includes coagulation, inflammation,
formation of granulation tissue, and remodeling.31−34 In severe
or chronic pathological conditions, the healing process is
locked in a state of chronic inflammation due to the presence
of cytokines, chemokines, and reactive oxygen species in the
milieu, that cause further damage related to oxidative stress.
Therapeutic agents currently used for wound healing include
agents promoting epithelization and antibiotics to eliminate
infection at the site of injury.35,36 In pathologies such as
diabetes, wound healing is impaired because of inadequate
trophic support due to peripheral nerve injury. This repair
requires trophic support in the form of nerve growth factor
(NGF), brain-derived neurotrophic factor (BDNF), and NT3
normally supplied and retrogradely transported from the target
tissues (skin and muscles) to the soma [dorsal root ganglia
(DRG)]. NGF promotes axonal growth in both the peripheral
and central nervous system.37−40 NGF binds to the nerve
terminal and is retrogradely transported to the cell body, where
it signals the transcription factor CREB to upregulate
prosurvival genes.40 BDNF is a 27 kDa protein, which when
excreted by microglia has been reported to increase neuronal
survival.41−43 NGF and BDNF exhibit wound healing proper-
ties and are excellent candidates for nerve repair.
Other agents have been proposed as therapeutics for wound
healing. Anti-oxidants, such as curcumin (diferuoylmethane), a
natural small hydrophobic and unstable molecule, have been
shown in phase 1 clinical trials to have high safety and wound
healing properties.44−47 CD109 is a membrane protein,
approximately 180 kDa, which binds to TGF-β and represses
TGF-β signaling in human keratinocytes.48−51 Because
curcumin and proteins such as CD109, NGF, and BDNF are
unstable in biological environments,52,53 it is advantageous to
incorporate them into nanocarriers to protect them from
hydrolytic and enzymatic cleavage to reach the site of injury.
We investigated the safety and effectiveness of PMOXA−
PDMS−PMOXA triblock copolymer in delivering small
hydrophobic molecules such as curcumin and larger hydro-
philic proteins such as NGF and BDNF to promote wound
healing and neural regeneration. We characterized the
polymersome structure and drug loading using transmission-
electron microscopy (TEM), asymmetrical flow field-flow
fractionation, UV spectroscopy, and dynamic light scattering
(DLS), while drug release was monitored using a dialysis bag
method. In addition, drug-loaded polymersomes were tested in
both 2D scratch assays as well as 3D organotypic cultures. This
study demonstrates that PMOXA−PDMS−PMOXA is non-
toxic and effective in delivering proteins and small molecules to
macrophages, fibroblasts, and neurons of the DRG and in the
hippocampus.
■ RESULTS AND DISCUSSION
To protect the photolabile curcumin and the labile proteins
(CD109, NGF, and BDNF) used in this study against harsh
environments, we incorporated them into PMOXA−PDMS−
PMOXA polymersomes.54 The triblock PMOXA−PDMS−
PMOXA copolymer was selected in view of its known chemical
stability and low toxicity.26,55 It was synthesized following a
known procedure,26 shown schematically in Figure S1. The
chemical structure of the copolymer and the synthetic
intermediates was ascertained by 1H NMR (Figure S2) and
19F NMR spectroscopy (Figure S3). The molar mass of the
copolymer (Mn = 9.84 kDa) was determined by
1H NMR
spectroscopy and gel permeation chromatography (GPC, Mn =
8.8 kDa, Mw/Mn = 1.4). The chemical structure of PMOXA−
PDMS−PMOXA is shown in Figure 1A, where the subscripts
25 and 75 represent, respectively, the numbers of MOXA and
DMS units in the blocks, as determined from the 1H NMR
spectrum of the copolymer.
Curcumin and various proteins were incorporated into
PMOXA−PDMS−PMOXA polymersomes (Figure 1B) using
the standard film hydration method. The hydrophobic nature
of curcumin allowed for its incorporation into the polymer-
some PDMS membrane with 82.3% encapsulation efficiency
(EE, Table 1). The curcumin content of PMOXA−PDMS−
PMOXA polymersomes was 2.4% (w/w), which corresponds
to an equivalent curcumin concentration of 167.57 μM for a
polymersome concentration of 2.5 mg/mL. Higher EE was
observed with NGF over bovine serum albumin (BSA);
however, because the mixing ration of protein/triblock was
much higher for BSA compared to NGF, these numbers
Figure 1. (A) Chemical structure of PMOXA−PDMS−PMOXA
copolymer. (B) Pictorial representation of polymersomes incorporat-
ing proteins (NGF, CD109, or BDNF) or hydrophobic molecules
(curcumin) and covalently labeled with rhodamine and the NMDAR
antagonist or agonist [memantine or R,S-tetrazolylglycine (TZG)].
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cannot be compared. A remarkable EE was achieved with NGF
(loading of 4.4 wt %) with an initial mixing ratio of 4.6%
(Table 1). A possible explanation for the high loading of NGF
is its net positive charge at neutral pH (pI of 9.3)56 compared
to the net negative charge of BSA (pI of 4.7)57 and its smaller
size (27 kDa vs 66.5 kDa). These results suggest that
PMOXA−PDMS−PMOXA is particularly a suitable nano-
carrier for trophic factors, such as NGF.
The size distribution of the polymersomes (60 < diameter <
400 nm), determined by DLS, was relatively wide (Figure S4)
with Rh values between ∼65 and 75 nm, depending on the
sample (Table 1). Additional analysis of the polymersomes was
performed by asymmetrical flow field-flow fractionation (AF4)
(Figures 2 and S11) to ascertain the incorporation of curcumin
and NGF and to measure polymersome sizes using the online-
DLS detector. This method is known to be more precise than
batch-mode DLS.58 The morphology of the polymersomes was
assessed before and after loading of NGF by TEM (Figure
S12). The electron micrographs show spherical structures with
diameters ranging from 10 to 140 nm. Size distribution after
loading NGF was narrower.
The fractograms presented in Figure 2A, which monitor the
absorption at 280 nm of the eluting species (left-hand
ordinate), indicate that curcumin- and NGF-loaded polymer-
somes elute at elution times similar to the elution time of
pristine polymersomes. The three eluting polymersomes have
similar RH values, as judged from the fractograms in Figure 2A
(right-hand ordinate). The size distributions of pristine
polymersome alone and curcumin-loaded polymersomes are
narrow, while polymersomes charged with NGF have a slightly
broader size distribution and a larger RH value. Rhodamine-
labeled polymersomes loaded with NGF were fractionated by a
modified elution protocol (method 2) designed to fractionate
free NGF (elution time ∼9 min) and NGF-loaded polymer-
somes (elution time ≈ 22 min). As seen in Figure 2B, the NGF
loading in the polymersomes was complete, with no detectable
free NGF dissolved in the polymersome suspension. The
rhodamine-labeled polymersomes incorporating NGF were
larger than empty polymersomes by about 25 nm in RH value
(Figure 2BC). We confirmed that NGF does not interact with
the regenerated cellulose membrane used in the AF4 channel
by analyzing NGF solutions of increasing concentration. The
elution signal of NGF measured by the UV detector was
proportional to the amount of NGF injected (Figure S5).
Release of curcumin by the polymersomes was assessed by a
dialysis-based method. The results presented in Figure S6
indicate that the polymersomes sustain the release of curcumin
over extended time. After a 48 h-incubation in a PBS saline
solution (pH 7.4), about 70% of the initial curcumin is
retained in the dialysis tube, hence within polymersomes.
Dialysis of free curcumin in the same conditions leaves less
than 4% curcumin in the dialysis bag. The NGF release from
the polymersomes was measured using a dialysis bag method
with a 50 kDa cutoff membrane. In this case, we used a
rhodamine-labeled NGF and measured the time-dependent
Rho-NGF content of the polymersomes remaining in the
Table 1. Characteristics of PMOXA−PDMS−PMOXA-Based Polymersomesa
complex feed ratiob (wt drug/wt PMOXA−PDMS−PMOXA) RH DLS (nm) LCc (%) EEd (%)
empty polymersomes N/A 66.1 ± 1.0 N/A N/A
polymersomes (BSA) 0.322 68.4 ± 1.3 13.55 48.6
polymersomes (curcumin) 0.03 62.3 ± 0.6 2.41 82.3
polymersomes (NGF) 0.046 65.2 ± 0.5 4.4 100
polymersomes (curcumin + NGF) 0.03 67.1 ± 2.1 2.32 80.5
0.019 0.18 100
polymersomes (CD109) 6.1 65.9 ± 4.0 20.72 4.3
polymersomes−memantine 0.01 77.0 ± 3.0 N/A N/A
polymersomes−TZG 0.01 75.5 ± 3.8 N/A N/A
aDLS = dynamic light scattering; LC = loading content; EE = encapsulation efficiency; BSA = bovine serum albumin; RhB = rhodamine; NGF =
nerve growth factor; TZG = R,S-tetrazolylglycine. bRatio of initial drug to copolymer used to prepare the formulation. cLC = weight percent of the
drug relative to copolymer in the final product. dEE = weight percent of drug content in the final formulation relative to amount added at the
beginning of the process.
Figure 2. AF4 fractograms of PMOXA−PDMS−PMOXA polymersomes. (A) AF4/UV/DLS fractograms monitored by the UV detector (left
ordinate) and by DLS (right ordinate), using the AF4 method 1, showing the UV absorbance at 280 nm as a function of elution time for empty
PMOXA−PDMS−PMOXA polymersomes (black curve), curcumin-loaded polymersomes (blue curve), and NGF-loaded polymersomes (red
curve) in phosphate-buffered saline (PBS; 10 mM, pH 7.4); PMOXA−PDMS−PMOXA concentration: 0.5 g/L. The scattered symbols represent
the hydrodynamic radii of the eluting polymersomes. (B) AF4 fractograms from AF4 method 2 of eluting rhodamine-labeled polymersomes with
and without NGF. Both samples were injected at similar PMOXA−PDMS−PMOXA concentration (2.0 g/L). The elution of the polymersomes
from the AF4 channel was also monitored by the fluorescence detector, the fluorescence elution profile matches well with the elution profile from
the UV/vis detector (data not shown). (C) Size distribution of empty, NGF-loaded, and BDNF-loaded polymersomes plotted as the differential
weight fraction as a function of the hydrodynamic radius (Rh).
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dialysis bag by spectrofluorometry using the emission of
rhodamine (λex = 552 nm). Nearly 60% of the NGF remained
encapsulated after a 24 h-incubation and 35% NGF was still
retained after 48 h (Figure S6C,D). The AF4 elution time of
the polymersomes (Figure S7A) increases as a function of
dialysis incubation time, which could be indicative of
polymersome swelling for longer dialysis times. In addition,
two new eluting species are observed, one at early elution times
(left arrow, Figure S7A) and one at late elution times (right
arrow for times 137 and 235 h). The peak at early elution
times corresponds to the triblock copolymers and free NGF
(Figure S5), which provides evidence of the destabilization of
the polymersomes. The large late eluting band (right arrow) is
due to species larger than the polymersomes (ca. 700−800 nm,
Figure S7B) could correspond to large aggregates which would
assemble from the swollen polymersomes.
PMOXA−PDMS−PMOXA polymersomes loaded, or not,
with curcumin and BSA were tested first in cell cultures of
macrophages and human fibroblasts to assess the toxicity of
polymer toward these cells. The cells selected are essential
components of the skin, a target tissue innervated by DRG that
we intend to use in the in vitro polymersomes evaluations in
addition to 3D DRG cultures. The first task was to show that
polymersomes are indeed not cytotoxic toward these cells,
which were not evaluated in previous studies of PMOXA−
PDMS−PMOXA polymersomes.
A concentration-dependent evaluation of pristine PMOXA−
PDMS−PMOXA polymersomes confirmed that they do not
impair the mitochondrial metabolic activity and do not reduce
the number of viable cells (Figure 3). J774A.1 macrophage
cells were also incubated for 24 h with polymersomes without
curcumin (triangle) or loaded with curcumin (square) and
curcumin alone (circle) (Figure 3). There are only significant
reductions in cell viability with relatively large free curcumin
concentrations (>10 μM), suggesting that the polymersomes
could be suitable for the delivery of curcumin.
Considering that the site of injury is invaded rapidly by
macrophages, it would be advantageous to exploit the
phagocytic and macropinocytic properties of macrophages
for delivery of drugs. This envisioned strategy promoted us to
investigate the rate and extent of polymersomes internalization.
Macrophages were treated with rhodamine-B (RhB)-tagged
polymersomes loaded with curcumin. Taking advantage of
intrinsic fluorescence of curcumin, we detected the location of
the polymersomes and their cargo (curcumin). Confocal
fluorescence imaging revealed that polymersomes are internal-
ized by J774A.1 macrophage cells within 5 min (Figure 4). Co-
localization of RhB with curcumin was confirmed, proving that
polymersomes are capable of delivering their cargo within cells.
Fibroblast migration is an indicator of wound healing, and
models, such as the “wound in the dish” model, allow the
evaluation of wound healing therapeutic agents. We used
scratch assays to determine if the biological activity of
compounds loaded into polymersomes is retained or, possibly,
enhanced compared to their free form. The experimental
conditions were set to measure the parameters of cell viability
and migration required for a successful wound healing using
both mouse and human fibroblasts (Figure 5). In this assay, an
enhanced migration of fibroblasts toward the scratched surface
is considered an indicator of promoted wound healing. We
tested CD109-loaded polymersomes. The following control
treatments were performed: (i) free fibroblast growth factor
(FGF, 0.3 μM, a positive control for cell migration), (ii) free
mitomycin C (MitC, 15 μM, an inhibitor of cell migration),
and (iii) pristine polymersomes for 24 h. Representative
fluorescent micrographs are illustrated in Figure 5A with
accompanying quantifications in Figure 5B. Treatment with
FGF enhanced the fibroblast migration (1.55 fold), whereas
treatment with MitC almost completely blocked fibroblast
migration. Results from this assay show a significant increase in
fibroblast migration, suggesting that FGF and CD109 might be
beneficial in wound healing as noted also in earlier
findings.48−51
Next, we investigated whether polymersome-loaded NGF
can increase neurite outgrowth in peripheral DRG dissociated
and 3D explant cultures. The restoration of nociceptive fields
post skin denervation through the collateral sprouting by
nearby undamaged nerves is dependent on endogenously
produced NGF.59,60 Skin and muscle are the target tissues
innervated by the nerves from the DRG. The experiments
using DRG dissociated and explant 3D cultures described next
were carried out to test if NGF retains its biological activity
when incorporated into PMOXA−PDMS−PMOXA polymer-
somes (Figure 6A,B).
Neurite outgrowth of dissociated DRG neurons was
enhanced significantly in the presence of NGF, with or
without polymersomes as seen in Figure 6A,B. The extent of
neurite outgrowth triggered by free NGF (50 ng/mL) and
polymersome-incorporated NGF was comparable, although
the NGF concentration within polymersomes was several-fold
higher. In NGF release kinetics (Figure S6C,D), we observed
that the amount of NGF released in the medium within 24 h
corresponds to 40% of the initial content. Nerves in the target
tissues (skin and muscle) are NGF-responsive in the wound
healing processes. Further studies are necessary to assess if and
how polymersome-incorporated trophic factors combined with
small molecules are advantageous in re-establishing normal
collateral sprouting and enhancing the rate of wound closure in
animal models. We tested also NGF-containing polymersomes
Figure 3. Polymersomes are well tolerated by macrophage cells.
J774A.1 macrophage cells were incubated for 24 h with equimolar
concentrations of polymersome nanoparticles (upward triangle),
curcumin-loaded polymersomes (square), and curcumin alone
(circle). (A) Mitochondrial metabolic activity was determined using
the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
(MTT) assay. The data are presented as the mean ± standard error
of the mean (SEM) obtained from at least three independent
experiments. (B) Cell viability was determined by cell counting. Cell
nuclei were labeled with Hoechst 33258 (10 μM, 10 min) and 9 fields
per sample were counted using a fluorescent microscope. The data are
presented as the mean ± SEM obtained from at least three
independent experiments. Statistically significant differences from
the untreated control were tested by Dunnett’s test and are indicated
by *p < 0.05, **p < 0.01, ***p < 0.001.
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in a 3D model of the peripheral nervous system (DRG
explants, Figure 6C,D) and noted that these polymersomes
significantly promote the neurite outgrowth. Three-dimen-
sional models both for peripheral and central nervous system
have a number of advantages over dissociated cultures
including retained connections, the ability to monitor long
term time-dependent changes from progenitor to fully
differentiated cells, and more reliable testing of therapeutic
interventions.61−63
Both peripheral nerves and central nervous system tissues
respond to BDNF. BDNF has been established as a crucial
trophic factor in brain development64 and neurological
Figure 4. Polymersomes are rapidly internalized by macrophage cells. J774A.1 macrophage cells were imaged using a live cell confocal microscope.
Cell nuclei were labeled with Hoechst 33258 or DRAQ5 (pseudo-color blue) and treated with polymersomes labeled with RhB (polymersomes-
RhB) (5 μM, based on polymer concentration). Images were acquired at t = 5 min. Scale bars = 10 μm. Representative fluorescent micrographs
from at least three independent experiments are shown.
Figure 5. (A) Fibroblast cell migration was measured using an in vitro scratch assay. Monolayer fibroblast cells (human and murine cells) were
scratched with a pipette tip prior to treatment. Control treatments were (i) FGF (0.291 μM), (ii) MitC (15 μM), and (iii) CD109 (10 μM) for 24
h. Representative fluorescent micrographs showing fibroblast cell migration after 24 h are shown in (A). The scratch is denoted by the dashed white
vertical lines. Scale bar = 200 μm. (B) Number of migrating cells to the vicinity of the scratch area expressed as the fold change in cell migration
with respect to the control (set to 1). The data are presented as the mean ± SEM obtained from at least three independent experiments performed
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disorders.65−67 Despite the positive neutrophic effects of
BDNF, clinical use of BDNF has been hampered by its
instability and rapid clearance; BDNF has a circulating half-life
of ∼10 min.68 We explored polymersome delivery of
neurotrophic protein BDNF in the central nervous system
using mouse hippocampal 3D organotypic slice cultures.
BDNF is a crucial regulator of memory formation in the
hippocampus.69 It is known to increase dendritic spine
density70,71 and to facilitate LTP.72 The hippocampus, an
area associated with memory formation, is especially sensitive
to traumatic brain injury (TBI). Even mild TBI, which does
not produce systematic vascular injury or neuronal loss, causes
dendritic and synaptic degeneration.73 Repeated mild TBI
leads to loss of long-term potentiation.74
We observed that polymersome-loaded BDNF has an
activity comparable to that of free BDNF on modulating
dendritic spine density in organotypic hippocampal cultures
(Figure 7A,B). While treatment with pristine polymersomes
(concentration-matched control, 211 μg/mL, 72 h) did not
significantly affect either the subtype or the total density of
dendritic spine density in serum-free media, application of free
BDNF (100 ng/mL, 72 h) or polymersome-incorporated
BDNF (100 ng/mL BDNF, 211 μg/mL polymersomes, 72 h)
significantly increased the total dendritic spine density
compared to both controls: hippocampi not treated with
polymersomes or treated with drug-free polymersomes in
serum-free media.
Spine morphology and density contribute to the synaptic
plasticity and functions. Several NMDA receptor agonists and
antagonists have been evaluated for modulating synaptic
functions in different models.75,76 Compounds investigated
include TZG and memantine, potent agonist and antagonist,
respectively.77,78 Memantine-coated gold nanoparticles have
been shown to target exclusively extrasynaptic NMDAR as the
large size prevents their entry in the synaptic cleft. This spatial
segregation allows blocking of extrasynaptic NMDAR without
affecting synaptic NMDAR. Savchenko et al. have shown that
the gold nanoparticles exhibit neuroprotective effect by
reducing glutamatergic cytotoxicity.79 We functionalized the
surface of polymersomes with TZG or memantine and imaged
them in mixed cortical cultures. Preliminary results (Figure
S13) indicate memantine, and TZG-functionalized rhodamine-
labeled polymersomes are predominantly found in neurons,
whereas rhodamine-labeled polymersomes that do not present
memantine or TZG are present in both glial cells and neurons.
Thus, follow-up studies should evaluate electrophysiological
parameters in models of central nervous system pathologies.
In summary, the study presented here demonstrates that
PMOXA−PDMS−PMOXA self-assembles to form highly
colloidally stable polymersomes that are nontoxic to murine
macrophages, human fibroblast cells, and 3D models (DRG
explants and hippocampal organotypic slice cultures). It
suggests that surface-modified PMOXA−PDMS−PMOXA
polymersomes could be useful nanocarriers for various trophic
factors, such as neurotrophin-3, insulin-like growth factor, and
in combination with small biologically active agents or synaptic
modulators. Collectively, PMOXA−PDMS−PMOXA poly-
mersomes merit further investigations in disease models in
Figure 6. (A) Dissociated DRG cultures treated with NGF-loaded
polymersomes increase neurite outgrowth. Phase contrast micro-
graphs. Scale bar = 100 μm. (B) Quantification of the neurite
outgrowth. Note the significant increase of neurite outgrowth with
NGF treatment. (C) Bright-field photomicrographs of DRG explants
after 4 days in culture. To enhance the contrast of neural cells against
the background, we used MTT (500 μg/mL, 3 h) and imaged with a
light microscope at 10× (Leica DMI6000B). Images were analyzed
using ImageJ. Scale bar = 400 μm. (D) Quantification of the neurite
area expressed as a percentage of control (PBS) (n = 8). The total
neurite area is normalized as shown in Figure S9. Error bars represent
SEM. *p < 0.05.
Figure 7. Polymersome-incorporated BDNF increases postsynaptic dendritic spine density of pyramidal neurons in organotypic hippocampal slice
cultures. Cultures were treated with BDNF (100 ng/mL), polymersome-loaded BDNF (100 ng/mL BDNF; 211 μg/mL polymersome), or empty
polymersomes (211 μg/mL) for 72 h in serum-free media (S−). Serum-containing media (S+) acted as a positive control. (A) Representative
photomicrographs of dendritic spines. Scale bar = 1.5 μm. (B) Quantification of spine density and subtype exposed to above conditions. n ≥ 12
spine segments from at least four independent samples. Statistical significance was assessed by one-way ANOVA followed by Dunnett’s test. *p <
0.05 compared to S− Ctrl.
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vivo to evaluate if they are superior to the unincorporated
agents at the peripheral and central target tissues. Polymer-
somes-containing proteins and small lipophilic molecules
provide new avenues for multidrug therapies to be considered
for interventions in neurological disorders.
■ EXPERIMENTAL SECTION
Chemicals. BSA (98%, electrophoresis), curcumin (from
Curcuma longa (Turmeric), FGF, laminin, PKH67, MitC,
MTT, RhB-isothiocyanate, Hank’s balanced salt solution
(HBSS), sodium chloride (NaCl), α,α,α-trifluorotoluene,
poly(dimethylsiloxane), 2-methyl-2-oxazoline, 1,2-dichloro-
ethane, trifluoroacetic anhydride, deuterated chloroform
(CDCl3), dimethyl-sulfoxide (DMSO), triethylamine (99%),
4-(dimethylamino)pyridine (DMAP, 99%), succinic anhydride
(99%), N-hydroxysuccinimide (NHS, 98%), N,N0-dicyclohex-
ylcarbodiimide (DCC, 99%), and anhydrous dichloromethane
(99.8%, containing 50−150 ppm amylene as stabilizer) were
purchased from Sigma-Aldrich (St. Louis, MO, USA).
Regenerated cellulose dialysis membranes [molecular weight
cutoff (MWCO): 3.5 kDa] were obtained from Spectrum Labs
(Rancho Dominguez, CA, USA). NGF 2.5S was purified from
male mouse salivary glands.59 Recombinant human CD109
protein was a gift of Dr. Anie Philip. Anhydrous ethanol was
purchased from GreenField Specialty Alcohols Inc. (Toronto,
ON, Canada). Sephacryl S-300 HR (Mw: 10−1500 kDa) was
purchased from GE Healthcare Bio-Sciences (Pittsburg, PA,
USA). PBS, Dulbecco’s modified Eagle’s medium (DMEM),
bovine calf serum, and penicillin−streptomycin were pur-
chased from Gibco (Thermo Fisher Scientific, Waltham, MA,
USA). Rat tail collagen and RPMI-1640 were purchased from
Invitrogen (Thermo Fisher Scientific, Waltham, MA, USA).
Paraformaldehyde was purchased from Fisher Scientific
(Waltham, MA, USA). Hoechst 33258 and AlexaFluor 488
goat anti-mouse were purchased from Molecular Probes
(Eugene, OR, USA). Trypsin was purchased from Worthing-
ton Biochemical Corp. (Lakewood, NJ, USA). β-Tubulin III
was purchased from EMD Millipore (Billerica, MA, USA).
Triblock Copolymer Synthesis. PMOXA25−PDMS75−
PMOXA25 was prepared following a known procedure (Figure
S1).26 Its synthesis is given in Supporting Information,
together with its structure and characterization by NMR
spectroscopy and GPC. The PDMS block has 75 units and the
PMOXA blocks have each 25 monomer units.
Polymersome Preparation and Loading. Polymer-
somes were formed by the film hydration method.26,80
PMOXA25-b-PDMS75-b-PMOXA25 (10 mg) was placed in a
round-bottom flask and dissolved with 2 mL of ethanol for 1 h.
The ethanol evaporated under reduced pressure at a
temperature of 40 °C, and the resulting thin polymer film
was dried for 4 h under vacuum at room temperature.
Subsequently, the film was rehydrated using a solution of PBS
(10 mM, pH 7.4, 137 mM NaCl, 4 mL, final PMOXA−
PDMS−PMOXA concentration of 2.5 mg/mL). The flask was
placed on a rotary agitator at room temperature for agitation
overnight and then stirred magnetically for 4 h with a small
Teflon stirring bar. The polymersome suspension was extruded
(11 times) through polycarbonate membranes (0.4 μm pore
size followed by 0.1 μm pore size, Avestin, Ottawa, ON,
Canada) to adjust the polymersomes size and sharpen the size
distribution.
Curcumin was loaded during the film formation by adding
0.3 mg of curcumin to the polymersome solution and
sonicated for 30 s prior to ethanol evaporation. For protein
loading, NGF 2.5S (26 kDa), BDNF (27 kDa), CD109 (180
kDa), or BSA (66.5 kDa) were dissolved in the PBS aqueous
solution used to rehydrate the polymer film. Excess free
protein was removed by filtration through centrifugal filter
units with an MWCO of 100 kDa (Amicon, EMD Millipore,
Billerica, MA, USA). Free CD109 was separated from
polymersome-encapsulated CD109 using Sephadex G-200 gel
filtration columns (Sigma-Aldrich, St. Louis, MO, USA).
Curcumin and Protein Loading Content Determina-
tion. For curcumin content determination, an aliquot of the
solution after rehydration was kept and diluted 200 times using
a solution of Tween 80 (1%) in PBS. An aliquot of identical
volume of the polymersomes suspension after extrusion and
removal of excess free curcumin was also diluted 200 times in a
Tween 80 solution. Both samples were analyzed by
fluorescence spectroscopy (λex = 431 nm, λem = 534 nm).
The EE was found by summing the areas under the emission
bands for the two aliquots, and the concentration of
encapsulated curcumin was calculated by multiplying the EE
and the initial concentration of curcumin used. The equations




weight of drug or protein in the polymersomes




Loading content (weight %)
weight of drug or protein in the polymersomes
total weight of the polymersomes tested
100%
The amount of protein in the polymersomes was determined
by UV absorbance spectroscopy. The absorption spectrum of
the sample after preparation was compared to that of
polymersomes prepared under identical conditions but without
proteins. The protein-loaded polymersomes were purified by
centrifugal filtration through 100 kDa membranes (EMD
Millipore, Billerica, MA, USA) or G-200 Sephadex columns for
CD109 separation to remove free protein. Fresh PBS was
added to the recovered polymersomes that were subjected to
three additional filtrations. A UV-absorption spectrum of the
retentate, diluted to its initial volume with fresh PBS, was
measured. The EE was determined as the ratio of the
absorbance of the suspensions after and before filtration (λ =
280 nm).
RhB Labeling of PMOXA−PDMS−PMOXA. To detect
the formation of polymersomes and their internalization in
cells (in vitro), the copolymer PMOXA−PDMS−PMOXA was
labeled by conjugating RhB isothiocyanate to the −OH end
groups. RhB isothiocyanate in dichloromethane (0.5 μmol)
was added to PMOXA−PDMS−PMOXA (0.01 mmol)
dissolved in dichloromethane (1 mL) and left to react for 10
h at RT. Excess RhB was removed by dialysis first in ethanol
and then again in deionized water (MWCO 5 kDa) for 48 h
followed by at least three exchanges with water. The RhB-
tagged polymer was isolated by lyophilization.
RhB Labeling of BSA and NGF. BSA (10 mg), or NGF
(0.5 mg), was dissolved in aqueous sodium bicarbonate buffer
(0.1 M, 1 mL, pH 8.5). A solution (50 μL) of RhB
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isothiocyanate in dimethylformamide (10 mg/mL), briefly
sonicated and stirred, was added to a stirred BSA solution (or
6.3 μL for NGF solution) for 1 h at room temperature. RhB-
labeled proteins were purified from free dye by two
consecutive elutions through Sephadex G25 columns.




PMOXA25−COOH) were synthesized as follows: succinic
anhydride (39 mg, 0.39 mmol), triethanolamine (50 μL, 0.36
mmol), and DMAP (6.9 mg, 0.06 mmol) were added to a
solution of HO−PMOXA25-b-PDMS75-b-PMOXA25−OH
(500 mg, 0.07 mmol) in anhydrous dichloromethane at 0 °C
under argon and reacted for 24 h. The reaction mixture was
dialyzed against dichloromethane for 2 days while changing the
dichloromethane four times. NHS-activated ester-modified
PMOXA25-b-PDMS75-b-PMOXA25 block copolymers (NHS−
PMOXA25-b-PDMS75-b-PMOXA25−NHS) were synthesized as
follows: NHS (30 mg, 0.26 mmol) and DCC (35 mg, 0.17
mmol) were added to an anhydrous dichloromethane solution
of HOOC−PMOXA25-b-PDMS75-b-PMOXA25−COOH (300
mg, 0.04 mmol) at room temperature under argon. The
mixture was maintained in this condition for 24 h. Finally, it
was dialyzed against dichloromethane for 2 days while
changing dichloromethane four times, followed by dialysis
against methanol to remove dichloromethane. The NHS−
PMOXA25-b-PDMS75-b-PMOXA25−NHS block copolymer
was characterized by 1H NMR spectroscopy (solvent:
CDCl3; Figure S10).
Polymersomes were prepared with 5% rhodamine-labeled
PMOXA−PDMS−PMOXA and 95% unlabeled PMOXA−
PDMS−PMOXA or 5% rhodamine-labeled PMOXA−
PDMS−PMOXA, 5% NHS-terminated PMOXA−PDMS−
PMOXA, and 90% unlabeled PMOXA−PDMS−PMOXA in
the case of drug-attached polymersomes. The triblocks were
mixed in methanol at the molar ratios described above.
Methanol was evaporated using a rotary evaporator. The film
was rehydrated at a concentration of 2.5 mg/mL in HEPES
buffer (10 mM, pH 7.4) for several hours. The solution was
sonicated for 30 s before being extruded through 0.4 μm
polycarbonate filters (Avestin) 11 times, followed by 0.1 μm
polycarbonate filters 11 times. A 10-fold excess, with respect to
the calculated amount of −NHS groups on the surface of the
polymersome, of an amine-containing drug over was added to
the extruded polymersomes. The excess unreacted drug was
removed by ultracentrifugal filtration through 3 kDa MWCO
filters (Pall Centrifugal Nanosep 3 kDa) spinning the tubes for
20 min at 7000g. The retentate was rinsed with HEPES buffer,
and the centrifugation was repeated three times. The last
retentate was diluted to obtain a polymersomes (2.5 mg/mL)
solution. The polymersome size was determined by AF4/UV/
DLS (see below).
Curcumin and NGF Release from Polymersomes.
Curcumin release from polymersomes was measured using the
dialysis bag method in a solution of PBS and Tween 80 (1%,
v/v). Tween 80 was added to solubilize curcumin, which has a
low solubility in PBS. A suspension of curcumin-loaded
polymersomes in PBS-Tween 80 (2 mL, CCur = 0.07 mg/mL)
was introduced in a dialysis tube (MWCO = 20 kDa, Slide-A-
Lyzer MINI Dialysis, 2 mL) and dialyzed against PBS-T (44
mL) at 37 °C. At predetermined time intervals, the entire
release medium was replaced by fresh medium to maintain
perfect sink conditions for curcumin. A solution of curcumin
(0.1 mg/mL in PEG400−water−dimethylacetamide (45:40:15
v/v/v) was used as a control. Curcumin concentration in the
release samples was measured using spectrofluorometry. The
concentration of curcumin in the dialysis compartment was
determined as well by taking aliquots (50 μL) and diluting
them 100-fold in ethanol before spectra analysis.
A solution of PMOXA−PDMS−PMOXA polymersomes
loaded with RhB-labeled NGF (5 mL, polymersome
concentration: 0.7 mg/mL) was placed in a dialysis tube
(MWCO: 50 kDa) and dialyzed against PBS (1 L) at 37 °C for
several days. Aliquots of the solution in the dialysis bag were
taken over time and analyzed by UV absorbance, fluorescence,
and AF4. The PBS solution was replaced with fresh PBS at
these times.
Asymmetrical Flow Field-Flow Fractionation. Informa-
tion about the instrument used and the two methods
developed for the analysis of the polymersomes can be found
in the Supporting Information section.
Transmission Electron Microscopy. Data were collected
on an FEI Tecnai 12 BioTwin 120 kV TEM. Images were
taken with an AMT XR80C CCD Camera System. Carbon-
coated grids were first treated in a glow-discharge apparatus set
at negative 25 mA for 30 s. Rapidly after, a drop of the
polymersome sample (stock concentration at 2.5 mg/mL, 5
μL) was deposited on the grid and left for 1 min. A Whatman
filter paper was used to wick away excess sample by slowly
bringing it into contact with the side of the grid. A uranyl
acetate solution (2%) was used as a negative staining agent, a 5
μL drop was deposited and left for 1 min before being wicked
away with a clean Whatman filter paper. The grids were placed
on a Whatman filter paper and left to dry in a Petri dish at
room temperature until imaging (>15 min).
Macrophage Cultures and Live Cell Imaging. Mouse
macrophage (J774A.1) cells (ATCC, TIB-67) were cultured in
DMEM containing 10% fetal bovine serum and 1% penicillin−
streptomycin. Cells were used between 5 and 25 passages.
In preparation for live cell imaging, macrophages were
seeded at a density of 20 000 cells/coverslip onto rat tail
collagen-coated cover slips (Fisher Scientific). Following cell
treatment, plasma membranes were labeled with 2 μM PKH67
for 15 min and subsequently washed with PBS containing 1%
BSA for 5 min. Prior to imaging, cells were washed with PBS
containing 1% BSA for 5 min. Fluorescence micrographs were
acquired with a Zeiss LSM 710 confocal microscope with Zeiss
Zen imaging software at 63× magnification.
MTT Cell Viability Assay. We assessed mitochondrial
activity, an indirect measure of cell viability using the
colorimetric MTT assay. Macrophage cells were seeded at
100 000 cells/well in 24-well plates (Sarstedt, Nümbrecht,
Germany). Following treatment, cell media was removed and
replaced with serum-free media containing MTT (0.5 mg/
mL), and cells were then incubated for 1 h at 37 °C. Following
the incubation, media were removed, cells were lysed, and
formazan was dissolved with DMSO. The dye absorbance was
measured at 595 nm using a Benchmark microplate reader
(Bio-Rad Life Science Research, Hercules, CA, USA). All
measurement points were done in triplicates in three or more
independent experiments.
Human and Mouse Fibroblast Cultures and Scratch
Assay. Human fibroblast cells and mouse 3T3 fibroblast cells
were seeded in DMEM containing 10% of fetal bovine serum
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and 1% penicillin−streptomycin. Cells were used between 5
and 25 passages.
Both mouse 3T3 fibroblasts cells and human fibroblasts were
seeded at 100 000 cells per well in 24 well plates, grown to
confluency and scratched with a 100 μL pipette and washed
with DPBS to remove detached cells. Fresh serum-containing
media was added, and cells were treated with (i) FGF (0.3
μM); (ii) MitC (15 μM); and (iii) curcumin (24.4 μM) for 24
h. Cells were then washed once with PBS and fixed with
paraformaldehyde (4%) for 15 min at room temperature. Cell
nuclei were labeled with Hoechst 33258 (10 μM, 10 min), and
fluorescent images of the scratch area were acquired.
Fluorescent images of cells were acquired at 20× with a
Leica DFC350FX monochrome digital camera connected to a
Leica DMI4000B inverted fluorescence microscope. Cell
migration was quantified using ImageJ and expressed as fold
change in the number of cells in the scratch area over the
control.
DRG Cultures Preparation and Imaging. Dissociated
DRG Preparation, Live Imaging, Neurite Outgrowth Assay.
L1−L5 DRG neurons were cultured from P5−P7 C57BL/6J
mice. The ganglia were dissociated in 0.1% trypsin in 1× HBSS
for 45 min at 37 °C followed by gentle mechanical trituration
using a fire-polished pipette. Dissociated cells were grown on
laminin-coated 96-well plates (Corning Inc., Corning, NY,
USA) and in growth media consisting of L-15 (Wisent Bio
Products, St. Bruno, QC, Canada) supplemented with
vitamins, cofactors, and penicillin−streptomycin.
In preparation for live cell imaging, dissociated DRG were
cultured in 50 ng/mL free NGF for 24 h. After 24 h, cells were
incubated for 24 h with a 50 000 ng/mL suspension of RhB-
labeled polymersomes loaded with NGF or a polymersome-
NGF suspension. Fifteen minutes before the end of treatment,
the cell nucleus was stained with Hoechst 33342 at 10 μM for
15 min. Cells were washed with PBS and imaged live using
fluorescence microscopy (a Leica DFC345FX monochrome
digital camera connected to a Leica DMI6000B inverted
fluorescence microscope).
To quantify neurite outgrowth, dissociated DRG were
treated with vehicle (PBS, control), empty polymersomes,
free NGF (50 ng/mL), or polymersome-loaded NGF (50 ng/
mL NGF) for 24 h. After 24 h in culture, cells were fixed with
4% paraformaldehyde for 20 min at room temperature and
permeabilized with 0.3% Triton X for 5 min. Neurons were
immunocytochemically labeled with β-tubulin III (1:500,
MAB1637) overnight at 4 °C and AlexaFluor 488 goat anti-
mouse (1:500, #A11005) for 1 h at room temperature. Images
were taken with a fluorescence microscope (Leica
DMI6000B). Neurite length was measured manually using
the ImageJ extension NeuronJ.81 The total neurite length in
pixels was normalized to the number of cell bodies and
expressed as percentage control.
Explant DRG Preparation and Explant Imaging. L3−L5
DRG were isolated from P5-7 mice as described above.
Explants were embedded in Matrigel (BD Biosciences,
Franklin Lakes, NJ, USA) and surrounded with RPMI-1640
supplemented with penicillin−streptomycin. Following embed-
ding, explants were treated with vehicle (PBS, control), empty
polymersomes, free NGF (50 ng/mL), or polymersome-loaded
NGF (50 ng/mL NGF).
After 4 days in culture, a MTT solution (500 μg/mL) was
added to the cultures and incubated for 3 h. Bright-field
pictures for the DRG were taken at 10× (Leica DMI6000B)
and analyzed using ImageJ. Images were inverted, and neurite
outgrowth was quantified as the total area of bright areas
(MTT-labeled regions), excluding the explant body, normal-
ized against the length of the explant body in the image, and
expressed as percentage control.
Primary Dissociated Hippocampal Neural Cultures
Preparation and Live Imaging. Primary dissociated hippo-
campal neural cultures were prepared from P0−P2 postnatal
C57/BL6 mice. Hippocampi were dissected and placed in ice-
cold 1× HBSS. The tissues were softened in 0.25% trypsin
[2.5% Trypsin (Thermo Fisher) diluted 10-fold into 1×
HBSS] for 20 min at 37 °C and 0.1% DNAse I (Sigma DN25)
for 5 min at 37 °C. Tissues were washed twice in plating media
(Neurobasal medium (Thermo Fisher) + 2 mM L-glutamine
(Thermo Fisher) + 10% fetal bovine serum + 1% penicillin−
streptomycin) and mechanically dissociated by triturating with
a fire-polished pipette. Cells were plated onto PDL (Sigma)-
coated chamber slides in plating media for 24 h and switched
to serum-free maintenance media (Neurobasal medium + 2
mM L-glutamine + 2% B27 + 1% penicillin−streptomycin).
Neural cultures were feed every 3 days by changing 50% of the
maintenance media and were used after 12 days in culture.
Cells were treated as described in the corresponding figure and
live-imaged using fluorescence microscopy (Leica DMI6000B).
All animal uses followed the McGill University animal use
guidelines and were approved by the McGill Animal Care
Committee.
Organotypic Hippocampal Culture Preparation, Imaging,
and Spine Classification. Preparation of organotypic hippo-
campal cultures were extensively described in Gaḧwiler et al.82
Cultures were prepared from P6-8 transgenic mice that express
Thy-1 driven eGFP in a subpopulation of CA1 neurons.
Hippocampi were transversely sliced 400 μm thick and
mounted onto glass coverslips using chicken plasma clot
(Cocalcol Biologicals; Reamstown, PA, USA). The culture
medium consisted of 25% heat-inactivated horse serum, 25%
HBSS, and 50% Basal Medium Eagle. Serum-free medium
consisted of 67% Basal Medium Eagle and 33% HBSS
supplemented with 12.5 mM glucose and 1.25 mM L-
glutamine. Cultures were incubated for 3 weeks in a roller
drum incubator before experimentation. Cultures were treated
with vehicle (PBS, control), empty polymersomes, free BDNF
(100 ng/mL), or BDNF-loaded polymersomes. After treat-
ment, cultures were fixed in 4% PFA overnight at 4 °C, washed
with PBS, and mounted onto microscope slides. Image stacks
of CA1 pyramidal neurons expressing eGFP were taken at Z =
0.2 μm. Images were acquired using an upright LEICA TCS
SP2 confocal microscope (Leica Microsystems, Heidelberg,
Germany) with an HVX PL APO 63× NA 1.4 oil immersion
objective. Image processing and spine classification were
performed as previously described.83
Statistical Analysis. Statistical significance was determined
by one-way ANOVA followed by Dunnett’s test, independent
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Methods section for the synthesis of triblock copolymer
and the AF4 methodology; schematic representation for
the synthesis of PMOXA−PDMS−PMOXA; H1 NMR
and 19F NMR charts of PMOXA−PDMS−PMOXA;
calibration curve for BSA and curcumin-loaded polymer-
somes; hydrodynamic radius distributions of polymer-
somes prepared by the rehydration method determined
by DLS; kinetics of the release of curcumin and NGF
from PMOXA−PDMS−PMOXA triblock-based poly-
mersomes; AF4 fractograms of PMOXA−PDMS−
PMOXA-based polymersomes loaded with NGF-rhod-
amine and functionalized with memantine and TZG;
AF4 calibration of NGF alone; electron micrographs of
polymersomes; fluorescent micrographs of primary
dissociated DRG cultures exposed to RhB-labeled
polymersomes containing NGF; and image trans-
formation for measurement of the neurite surface area
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